# Viridian Therapeutics, Inc. (VRDN): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Viridian Therapeutics, Inc. (VRDN) is 19/100, ranked against 24,000+ stocks in 35 markets (Quality 18, Value 24, Momentum 57, each scored against its sector).

- StockRank: 19/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 18, Value 24, Momentum 57: each a 0-100 percentile within Healthcare.
- Position: #21,551 overall, #1,959 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 23.34 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 20.0M; directors sold USD 348K.

Source: https://moatmap.ai/stock/VRDN
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker